Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy Improves Bone Mineral Loss After Salpingo-oophorectomy for Ovarian Cancer

By

In patients who undergo risk-reducing salpingo-oophorectomy, BMD screenings are underutilized in spite of the prevalence of bone mineral loss in this population. Hormone replacement therapy can address BMD loss in these women.

Patient factors change risk for HRT-related breast cancer

By

The impact of hormone replacement therapy (HRT) use on breast cancer risk varies according to patient race/ethnicity, body mass index (BMI), and breast density, researchers have learned.

HRT-related breast cancer risk varies by BMI, race, breast density

HRT-related breast cancer risk varies by BMI, race, breast density

HRT-linked risk up for white, Asian, Hispanic women; for low/normal BMI and dense breasts.

ONS Connections: Pretreatment depression, anxiety, and poor physical functioning associated with non-adherence to hormonal therapy in breast cancer patients

By

Taking a lower percentage of prescribed doses of hormonal therapy was associated with higher pre-therapy levels of depression and anxiety and with poorer physical functioning.

AACR: Study links long-term estrogen use to breast cancer

AACR: Study links long-term estrogen use to breast cancer

Risk increased with estrogen, estrogen progesterone; no increase in fatal breast cancer.

Estrogen use after hysterectomy protects against breast cancer

Women who used estrogen after hysterectomy appear to be nearly 25% less likely to develop breast cancer and nearly 63% less likely to die from it.

Stopping hormone therapy may quickly lower breast cancer rates

Discontinuing hormone therapy may lead to tumor regression in breast cancer, indicate the results of a new study.

Estrogen-Only HRT Lowers Breast CA in Women With Hysterectomy

Estrogen-Only HRT Lowers Breast CA in Women With Hysterectomy

The use of estrogen-only after hysterectomy lowers the risk of breast cancer, but largely in groups already at low risk of breast cancer.

HT cessation linked with less mammography use

The first drop in mammography rates since 1987 among age-eligible women occurred in 2005, and at least partial blame can be pinned on the decline in the use of hormone therapy.

Estrogen use not associated with increased lung cancer risk

By

Postmenopausal women who use estrogen do not increase their risk for lung cancer mortality, according to a study published in The Journal of the National Cancer Institute (2010 Aug 13. [Epub ahead of print]).

Hormone therapy linked to higher incidence of breast cancer

By

Breast cancer risk increases with long-term use of hormone therapies, according to a study that analyzed the California Teachers Study.

Progestin-type may determine breast cancer risk in postmenopausal women

By

Breast cancer risk in postmenopausal women varies depending on the type of progestin used in hormone replacement therapy, according to a study published in Cancer Prevention Research (2010 Aug 10 [Epub ahead of print]).

Hormonal therapy plus radiation improves prostate cancer survival

By

Short-term hormonal therapy increases overall survival in patients with prostate cancer, according to a study presented at the 2010 Genitourinary Cancers Symposium.

HRT and breast cancer

GPs should advise women to continue taking HRT, despite claims linking it to breast cancer, according to an expert on the menopause.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs